COST-EFFECTIVENESS OF DONEPEZIL IN THE TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE: AN UPDATE

被引：0
|
作者：
Chyr, L. C. [1 ]
Yapici, H. O. [1 ]
Padula, W., V [1 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1399
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND26
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [31] Treatment of Alzheimer's disease with cholinesterase inhibitors in Germany: A cost-effectiveness study
    Faltraco, F
    Happich, M
    Reisig, V
    Teipel, SJ
    Moeller, HJ
    Hampel, H
    NEUROBIOLOGY OF AGING, 2004, 25 : S336 - S336
  • [32] Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation
    Susanne Hartz
    Denis Getsios
    Sunning Tao
    Steve Blume
    Grant Maclaine
    BMC Neurology, 12
  • [33] Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation
    Hartz, Susanne
    Getsios, Denis
    Tao, Sunning
    Blume, Steve
    Maclaine, Grant
    BMC NEUROLOGY, 2012, 12
  • [34] Economic Evaluation of Treatment Options in Patients with Alzheimer's Disease A Systematic Review of Cost-Effectiveness Analyses
    Pouryamout, Laura
    Dams, Judith
    Wasem, Juergen
    Dodel, Richard
    Neumann, Anja
    DRUGS, 2012, 72 (06) : 789 - 802
  • [35] Effectiveness of donepezil in treating Alzheimer's disease
    Garcia, A
    CANADIAN FAMILY PHYSICIAN, 1999, 45 : 1858 - 1859
  • [36] The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model
    Bond, M.
    Rogers, G.
    Peters, J.
    Anderson, R.
    Hoyle, M.
    Miners, A.
    Moxham, T.
    Davis, S.
    Thokala, P.
    Wailoo, A.
    Jeffreys, M.
    Hyde, C.
    HEALTH TECHNOLOGY ASSESSMENT, 2012, 16 (21) : 1 - +
  • [37] EFFECT OF MORTALITY ON COST-EFFECTIVENESS MODELING OF DISEASE-MODIFYING TREATMENT FOR ALZHEIMER'S DISEASE
    Aye, S.
    Jonsson, L.
    VALUE IN HEALTH, 2022, 25 (12) : S483 - S483
  • [38] Effect of mortality in cost-effectiveness modeling of disease-modifying treatment for Alzheimer's disease
    Aye, Sandar
    Jonsson, Linus
    Gustavsson, Anders
    Tate, Ashley
    Ptacek, Sara Garcia
    Eriksdotter, Maria
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2023, 15 (01)
  • [39] THE TIMELY DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE: MICROSIMULATING COST-EFFECTIVENESS IN THE CZECH REPUBLIC
    Broulikova, Hana M.
    Kucera, Matej
    Arltova, Marketa
    DEMOGRAFIE, 2021, 63 (04) : 216 - 225
  • [40] The cost-effectiveness implications of suboptimal treatment for different severities of Alzheimer's disease in the UK
    Zala, Darshan
    Chan, Dennis
    McCrone, Paul
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (02) : 307 - 315
12345